🔴 Humacyte is trading 5.69% down today with no confirmed catalyst

Humacyte is trading at $0.61, down 5.69%, with no confirmed catalyst identified for today’s decline.

• No fresh August 31, 2026 company-specific announcement or filing was identified.
• August 24 FDA discussions concerned a supplemental dialysis-access BLA but do not directly explain today’s move.
• Broader markets are modestly lower; prior biotech weakness and hawkish-rate concerns remain background pressure, while reliable coverage does not establish a specific cause.